Institution information unavailable
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
139
Publications
2311
Citations
87249
i10-index
903
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Vedolizumab as Induction and Maintenance Therapy f... | 2013 | 2816 |
STRIDE-II: An Update on the Selecting Therapeutic ... | 2021 | 2557 |
Selecting Therapeutic Targets in Inflammatory Bowe... | 2015 | 1817 |
Tofacitinib as Induction and Maintenance Therapy f... | 2017 | 1691 |
Ulcerative colitis | 2020 | 1507 |
The second European evidence-based Consensus on th... | 2010 | 1491 |
Ustekinumab as Induction and Maintenance Therapy f... | 2019 | 1152 |
Ulcerative Colitis | 2011 | 1082 |
Epithelial NEMO links innate immunity to chronic i... | 2007 | 1062 |
Expanded allogeneic adipose-derived mesenchymal st... | 2016 | 1053 |
Silvio Danese is a researcher with 2311 publications and 87249 citations. Their research focuses on . With an h-index of 139, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Silvio Danese and 250M+ other papers.
Citations per publication by year